Cargando…
Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice
Inflammatory bowel disease (IBD) is one of the most common intestinal disorders, with increasing global incidence and prevalence. Numerous therapeutic drugs are available but require intravenous administration and are associated with high toxicity and insufficient patient compliance. Here, an oral l...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987780/ https://www.ncbi.nlm.nih.gov/pubmed/36861451 http://dx.doi.org/10.1080/10717544.2023.2183821 |